| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 3e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 2e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |